ECM
FLXN

Element Capital Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Element Capital Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-21,742
Closed -$271K – 837
2019
Q1 		$271K Buy
+21,742
New +$291K 0.01% 629

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Element Capital Management's FLXN Position: Q2 2019 in Review

Element Capital Management sold out of Flexion Therapeutics, Inc. (FLXN) in Q2 2019, closing a stake of 21,742 shares — an estimated $271K sold.

Element Capital Management first reported a position in FLXN in Q1 2019 and held it in 1 quarter. The position peaked at $271K in Q1 2019. 129 funds tracked by Wall St. Rank hold FLXN as of Q2 2019.

  • Element Capital Management reported no remaining Flexion Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Element Capital Management sold 21,742 Flexion Therapeutics, Inc. shares in Q2 2019, an estimated $271K.
  • Element Capital Management first reported a position in Flexion Therapeutics, Inc. in Q1 2019 and held it in 1 quarter.
  • Element Capital Management's Flexion Therapeutics, Inc. position peaked at $271K in Q1 2019.
  • 129 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q2 2019.

Based on Element Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.